Found 6 results
Name | Type of Offering | Accepted Date |
---|---|---|
BioClin Therapeutics, Inc.
|
D | 2014-04-17 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-14-000001
Exclusions or Exemptions
506b
Accepted Date
2014-04-17
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Option To Acquire
|
||
Rainier Therapeutics, Inc.
|
D | 2019-02-12 16:07:23 |
Amount To Be Raised
$20,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-19-000002
Exclusions or Exemptions
506b
Accepted Date
2019-02-12 16:07:23
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioClin Therapeutics, Inc.
|
D/A | 2018-05-14 09:19:24 |
Amount To Be Raised
$50,003,996
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-05-14 09:19:24
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioClin Therapeutics, Inc.
|
D | 2014-06-04 |
Amount To Be Raised
$9,982,500
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-14-000003
Exclusions or Exemptions
506b
Accepted Date
2014-06-04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
BioClin Therapeutics, Inc.
|
D | 2017-03-20 18:14:15 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-17-000002
Exclusions or Exemptions
506b
Accepted Date
2017-03-20 18:14:15
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Rainier Therapeutics, Inc.
|
D | 2019-07-26 12:19:35 |
Amount To Be Raised
$19,200,000
Associated Brokers / Dealers
N/A
CIK Number
0001605096
Filed Document
0001605096-19-000003
Exclusions or Exemptions
506b
Accepted Date
2019-07-26 12:19:35
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|